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Abstract
Introduction: Adherence to antiretroviral 
medication results in reduced HIV 
transmission and improved health outcomes, 
yet challenges with medication adherence 
remain. 
Methods: A Collaborative Care Program 
was developed with a community pharmacy 
integrating a multi-dose adherence packaging 
service. We surveyed program participants to 
assess their satisfaction with this program.
Results: All participants reported that the 
blister packaging program helped them 
miss fewer doses of their ART medication. 
Similarly, all agreed that they would 
recommend the blister packaging program to 
others. 
Conclusion: We found an overall positive 
sentiment toward the program, that the 
program helped with reducing missed doses, 
and all patients would recommend the 
program to others.
Introduction
Since the beginning of the HIV epidemic, 
more than 70 million people have been 
infected with the virus, and an estimated 
35 million have died. By the end of 
2016, approximately 36.7 million people 
around the world were living with HIV.1 
Antiretroviral therapy (ART) allows for 
immune reconstitution in people living with 
HIV (PLWH) by suppressing HIV replication 
and increasing CD4+ counts. Increased 
access to ART has prevented a projected 
5.2 million AIDS-related deaths in low- and 
middle-income countries from 1995 – 2010.2 
Adherence to antiretroviral regimens can 
reduce HIV transmission and increase the 
patient’s life expectancy.3 However, an 
estimated 50% of PLWH fail to take their 
medications as prescribed.4 Inconsistent 
ART adherence can lead to treatment failure 
and drug resistance, increasing the risk for 
development of AIDS and AIDS-related 
conditions leading to death.5 Reasons for 
medication non-adherence vary, including 
inability to afford medications, drug regimen 
complexity, poor health literacy, forgetfulness, 
impact of co-existing psychiatric conditions, 
transportation problems, and social or 
self-stigmatization.4 Some strategies to 
improve medication adherence include 
dose simplification, specialized packaging, 
and directly observed therapy.6 There is an 
association between patient satisfaction with 
health care services and adherence to ART, 
and using an integrated specialty pharmacy to 
provide refill reminders, medication delivery, 
and adherence calls have led to improved 
immune markers and viral suppression in 
patients living with HIV.7,8
Beginning in 2013, the Nebraska Medicine 
HIV Clinic partnered with Elmwood 
Pharmacy (a community pharmacy adjacent 
to the clinic) to develop a Collaborative 
Care Program (CCP). As part of the CCP, 
medications are placed in multi-dose 
adherence blister packaging which is 
dispensed every two weeks. The packages 
include the patient’s daily medications 
including their ART, with as needed 
medications dispensed in separate bottles. 
Patients receive two weeks supplies of 
medication, unless they live outside the 
Omaha metro area, which necessitates mail 
delivery of one month’s worth of medication. 
Patients are required to return the previous 
two packages in order to receive new 
packages. This returning of their old packages 
enables the pharmacy to keep records of 
missed doses and recommend adjustment in 
timing of medication dosing based on their 
findings.
The patients are referred to the blister 
packaging program for a variety of reasons. 
Some are visually impaired or require closer 
supervision, many are prescribed multiple 
medications, and most simply forget to take 
their medication. Preliminary data from the 
pilot program has demonstrated an impact on 
virologic suppression, although patient-related 
attitudes and satisfaction with the program 
have not previously been assessed.9 This 
information could be utilized to improve the 
program and further tailor it to our patients, 
as it is a valuable adherence tool for PLWH. 
Therefore, we aimed to evaluate attitudes 
and satisfaction with the blister packaging 
program. 
Methods
People living with HIV receiving care 
at the UNMC HIV Clinic and receiving 
medications via blister packaging from the 
Elmwood Pharmacy were invited to complete 
a survey. How did you develop the survey? 
Patients who enrolled in the blister packaging 
program from 2013 through December 2018 
were invited to participate. Paper surveys 
were mailed out to patients’ home address 
on file and if not completed/returned by 
the time of an in-person visit, the survey 
was administered on-site, by telephone, or 
by the pharmacy courier. The survey was 
administered in Spanish for those patients that 
required it. 
Data Storage. Study data were collected 
and managed using the REDCap electronic 
data capture tools hosted at the University of 
Nebraska Medical Center. Service and support 
is provided by the Research Information 
Technology Office (RITO), which is funded 
by the Vice Chancellor for Research.
Data Analysis. The descriptive analysis 
uses frequencies and percentages to 
describe categorical data and medians and 
interquartile ranges to describe continuous 
data. Given the relatively small size of the 
sample, possible associations of patient 
demographic and clinical characteristics with 
medication adherence, barriers to medication 
adherence, and satisfaction with the use of 
blister packaging were not evaluated using 
hypothesis testing methods.
Ethical approval. This project was reviewed 
and approved as minimal risk by the 
University of Nebraska Medical Center 
Institutional Review Board (607-18-EP).
Results
Forty-four patients met criteria for inclusion. 
Twenty-three surveys were completed (52.3% 
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response rate); eight returned by mail, 13 
administered in-person during a clinic visit, 
one administered over the phone, and one 
returned via a courier. Three patients declined 
participation and 18 patients did not respond. 
The median number of years living with HIV 
and on ART were 16.2 and 8.7, respectively. 
The median age of the participants was 
54, with almost equal distribution of sex 
assigned at birth. The participants were 
largely non-Hispanic white (52%) with 
24% and 19% of participants identifying as 
Black and Hispanic, respectively. Eighty-two 
percent of participants were unemployed, 
and 60% reported income below 100% of 
the Federal Poverty Level. Most participants 
had suppressed viral loads (95%; <50 copies/
mL) with a median CD4+ count of 621 cells/
mm.3 A large majority of respondents had at 
least one mental health diagnosis (81%) and 
38% reported substance use. Twenty-two 
respondents (95%) were on a multiple-pill 
regimen taken once daily, and 85% had no 
change in their ART medication regimen. 
A large majority (71%) were taking an 
integrase strand transfer inhibitor-based ART 
regimen. Thirty-eight percent of participants 
reported having someone at home who helped 
them remember to take their medication. A 
summary of patient demographics can be 
found in Table 1.
The most common reasons for missed doses 
identified by participants were “forgetting” 
(58 %), and “not feeling like taking the 
medicine” (11%) (Figure 1). All participants 
reported that the blister packaging program 
helped them miss fewer doses of their ART 
medication. Similarly, all agreed that they 
would recommend the blister packaging 
program to others. The most helpful aspect of 
the program reported was being able to see 
when they had missed a dose (100% reported 
this as being “very helpful”). Other helpful 
aspects included the medicine being delivered 
to their home (90% reported “very helpful”) 
and better organization (95% reported “very 
helpful”) (Figure 2).
Discussion
In this survey study to evaluate the 
perspectives and satisfaction of patients 
enrolled in the CCP blister packaging 
program, nearly all participants reported high 
satisfaction. Many respondents appreciated 
being able to see potential missed doses 
and all respondents indicated satisfaction 
with the program by stating that they would 
recommend the program to others. Our 
findings that missed doses are often due 
to forgetfulness and lack of transportation 
aligns with other reported common adherence 
barriers.10 Patients who participate in this 
blister packaging program were enrolled 
due to prior issues with non-adherence. 
Almost all of the patients in the program who 
responded to the survey had controlled viral 
loads at the time of the survey, indicating 
that the patients were likely having improved 
adherence with their ART after enrollment 
in the program. An early evaluation of this 
blister packaging program cohort showed 
that program participants had improved viral 
suppression after enrollment.9 The participant 
population had a high prevalence of comorbid 
conditions, predominantly related to mental 
health diagnoses. Despite many participants 
being on single-tablet regimens of ART, 
Table 1.
Participant demographics and clinical characteristics.
Characteristic Median (IQR) or n (%)
Age, years 54 (48, 58)


























Out of work (involuntary)







Below 100% of the federal 
poverty level




HIV Duration, years 16.2 (12.2, 21.7)
Characteristic Median (IQR) or n (%)
ART Duration, years 8.7 (4.9, 14.4)
Last Viral Load < 50 copies/mL 20 (95)


















Total Number of Medications 9 (7, 11)
Mental Health Diagnosis 17 (81)
History of Opportunistic Infection 5 (24)
Diabetes 7 (33)
Hypertension 11 (52)
Cardiovascular Disease 13 (62)
Kidney Disease 3 (14)
Substance Use 8 (38)
HIV: Human Immunodeficiency Virus
ART: Antiretroviral Therapy
 Didn't want other people to know
 Did not like being reminded of my HIV
 Too many pills
 Side effects
 Too busy
 No way to get to the pharmacy










Figure 1. Patient-reported biggest reasons for missed doses of ART (n = 21).
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their concomitant comorbidities resulted in 
increased pill burden, which could impact 
adherence without the blister packaging 
program. 
The patients enrolled in the blister packaging 
program are a small percentage of the 1300-
1400 patients in the clinic on ART. To study 
this process on a larger scale, a multi-center 
study involving other community pharmacies 
could be useful. Furthermore, a program 
like this could have applications outside of 
HIV care, for patients followed by primary 
care clinicians managing conditions like 
hypertension, hyperlipidemia, and diabetes. 
Increased adherence has previously been 
demonstrated in trials of blister packaging 
programs for psychiatric medications and 
hypertensive medications.11,12 A study 
investigating the use of blister packaging 
for multiple medications in elderly patients 
showed improvements in blood pressure 
and LDL measurements.13 This broader 
application could subsequently lead to 
improved overall outcomes of our patient 
populations, particularly those at risk for more 
severe disease. These previous studies looked 
only at efficacy of the programs, and further 
studies on patient satisfaction may be helpful.
Strengths of this study include the relatively 
high response rate for a survey study, with 
52% of the surveys sent out being completed. 
The generalizability of the study is limited 
by the small sample size. Another limitation 
of note is a response bias, in that the 
demographic and viral suppression data were 
only collected in patients who responded to 
the survey. More motivated patients were 
more likely to participate in the survey, 
therefore these results (both satisfaction and 
corresponding markers of HIV control) may 
not be as applicable in patients who did not 
complete the survey.
Overall, the results show a high level of 
participant satisfaction with the blister 
packaging program. Improvements in 
medication adherence through the use of a 
collaborative pharmacy-based adherence 
packaging program may increase PLWHs 
ability to achieve and maintain virologic 
suppression.
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Figure 2. Patient-reported most helpful aspects of blister packaging program (n = 21). 
